Jones Hill Capital LP
29 holdingsFiling period: 2026-06-30Current AUM: $418.4Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | BMRN | Biomarin Pharmaceutical Inc | 1.43M | $81.9M | $81.1M | 19.37% | +163.2K | 2026-06-30 |
| 2 | GILD | Gilead Sciences Inc | 343.0K | $43.3M | $53.9M | 12.89% | -- | 2026-06-30 |
| 3 | ARQT | Arcutis Biotherapeutics Inc | 1.09M | $28.6M | $35.1M | 8.39% | -- | 2026-06-30 |
| 4 | MDGL | Madrigal Pharmaceuticals Inc | 52.5K | $28.2M | $23.8M | 5.69% | -- | 2026-06-30 |
| 5 | BCAX | Bicara Therapeutics Inc | 892.6K | $26.5M | $15.7M | 3.76% | -367,515 | 2026-06-30 |
| 6 | RLMD | Relmada Therapeutics Inc | 3.66M | $25.3M | $12.0M | 2.87% | +3.31M | 2026-06-30 |
| 7 | TRVI | Trevi Therapeutics Inc | 1.34M | $25.0M | $17.3M | 4.14% | +969.0K | 2026-06-30 |
| 8 | — | Pharvaris N V | 677.9K | $23.4M | $23.4M | 5.60% | +510.9K | 2026-06-30 |
| 9 | XENE | Xenon Pharmaceuticals Inc | 367.9K | $22.2M | $13.4M | 3.21% | -- | 2026-06-30 |
| 10 | ANIP | Ani Pharmaceuticals Inc | 233.8K | $19.4M | $17.2M | 4.12% | -84,783 | 2026-06-30 |
| 11 | IMCR | Immunocore Hldgs PLC | 512.9K | $16.3M | $16.5M | 3.94% | -- | 2026-06-30 |
| 12 | AMLX | Amylyx Pharmaceuticals Inc | 894.1K | $16.1M | $25.5M | 6.10% | -704,736 | 2026-06-30 |
| 13 | INSM | Insmed Inc | 122.4K | $13.0M | $11.6M | 2.78% | -- | 2026-06-30 |
| 14 | NUVL | Nuvalent Inc | 98.4K | $12.2M | $12.2M | 2.91% | -202,388 | 2026-06-30 |
| 15 | CAPR | Capricor Therapeutics Inc | 420.8K | $10.1M | $2.6M | 0.62% | -488,456 | 2026-06-30 |
| 16 | ACRS | Aclaris Therapeutics Inc | 1.76M | $9.3M | $6.7M | 1.61% | -- | 2026-06-30 |
| 17 | IMUX | Immunic Inc | 539.8K | $8.3M | $3.9M | 0.93% | -- | 2026-06-30 |
| 18 | ORIC | Oric Pharmaceuticals Inc | 747.3K | $8.1M | $10.2M | 2.43% | -- | 2026-06-30 |
| 19 | TNXP | Tonix Pharmaceuticals Hldg C | 625.4K | $8.0M | $3.2M | 0.77% | +173.3K | 2026-06-30 |
| 20 | SNDX | Syndax Pharmaceuticals Inc | 340.0K | $7.4M | $4.6M | 1.10% | -- | 2026-06-30 |
| 21 | OLMA | Olema Pharmaceuticals Inc | 574.2K | $7.2M | $4.0M | 0.96% | -- | 2026-06-30 |
| 22 | VIR | Vir Biotechnology Inc | 659.2K | $6.7M | $6.9M | 1.64% | -539,000 | 2026-06-30 |
| 23 | CRBP | Corbus Pharmaceuticals Hldgs | 653.6K | $6.1M | $2.7M | 0.65% | -- | 2026-06-30 |
| 24 | DNTH | Dianthus Therapeutics Inc | 57.1K | $5.6M | $4.5M | 1.07% | -- | 2026-06-30 |
| 25 | VRTX | Vertex Pharmaceuticals Inc | 11.1K | $5.5M | $6.0M | 1.42% | -97,480 | 2026-06-30 |
← Scroll →
Page 1 of 2